Alex Harding, MD, MBA, Senior Associate

Alex Harding is a senior associate and focuses on building companies to create life-changing therapies for patients. He is also a practicing physician who sees patients at Massachusetts General Hospital. His patients are the motivation for his work at Atlas.

At Atlas, Alex was on the founding team and now observes on the board of Triplet Therapeutics and several early stage companies. He also observes on the board of HotSpot Therapeutics and the Science & Technology committee of Synlogic. He observed on the board of Rodin Therapeutics before it was acquired.

Prior to joining Atlas in 2018, Alex completed his residency in internal medicine at Massachusetts General Hospital. He received an MD from Johns Hopkins School of Medicine and was selected for the Alpha Omega Alpha medical honors society. He was awarded the W. Barry Wood Student Research Award for his work describing a novel water treatment method for tropical settings using psoralens found naturally in citrus fruit to block DNA transcription and replication in pathogenic organisms. He graduated from Harvard Business School with an MBA and completed his undergraduate education at Yale University, where he founded a non-profit called Water Ecuador, which provided clean and affordable drinking water to thousands of people in a low-income, rural part of Ecuador.

He lives with his wife and son in the South End neighborhood of Boston. He is a regular contributor on the Timmerman Report.